Hudson Bay Capital Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.1M Buy
+200,000
New +$10.8M 0.04% 286
2020
Q4
– Sell
-10,000
Closed -$619K – 707
2020
Q3
$619K Buy
+10,000
New +$651K 0.01% 456
2020
Q2
– Sell
-26,000
Closed -$1.23M – 566
2020
Q1
$1.23M Buy
+26,000
New +$1.3M 0.03% 305
2019
Q4
– Sell
-40,000
Closed -$1.96M – 509
2019
Q3
$1.96M Buy
+40,000
New +$2.01M 0.05% 265
2019
Q2
– Sell
-200,944
Closed -$9.97M – 684
2019
Q1
$9.97M Buy
+200,944
New +$9.04M 0.13% 153
2018
Q2
– Sell
-163,624
Closed -$6.18M – 966
2018
Q1
$6.18M Sell
163,624
-159,368
-49% -$5.63M 0.13% 181
2017
Q4
$10.5M Buy
322,992
+22,992
+8% +$731K 0.22% 77
2017
Q3
$9.07M Buy
300,000
+200,000
+200% +$5.93M 0.23% 98
2017
Q2
$2.94M Buy
+100,000
New +$2.73M 0.06% 280

Other funds holding TECH

Hudson Bay Capital Management's TECH Position: Q2 2026 in Review

Hudson Bay Capital Management opened a new position in Bio-Techne (TECH) in Q2 2026: 200,000 shares worth $14.1M. The stake represents 0.04% of the portfolio and ranks #286 among its holdings. This is a return to the name: Hudson Bay Capital Management previously reported a position in TECH as recently as Q3 2020.

Hudson Bay Capital Management first reported a position in TECH in Q2 2017 and has held it in 9 quarters since. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Hudson Bay Capital Management held 200,000 shares of Bio-Techne worth $14.1M as of Q2 2026.
  • Bio-Techne was a new Hudson Bay Capital Management position in Q2 2026.
  • Bio-Techne made up 0.04% of Hudson Bay Capital Management's portfolio in Q2 2026, its #286 holding.
  • Hudson Bay Capital Management first reported a position in Bio-Techne in Q2 2017 and has held it in 9 quarters since.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.